Service applies CLSI M100 guidelines to PCR results, delivering clear insights on pathogens and resistance markers to support physicians and labs BIRMINGHAM, Ala., Sept. 18, 2025 /PRNewswire/ -- ...

PathogenDx's Microarray Detection Platform is the fastest and most cost-effective test for UTI detection with higher throughput for efficient and accurate diagnosis. Neeraj Jadhav, Industry Analyst at ...

The MarketWatch News Department was not involved in the creation of this content. Service applies CLSI M100 guidelines to PCR results, delivering clear insights on pathogens and resistance markers to ...

A recent McKnight’s article on a new consensus statement recommending against PCR urine testing in long-term care raises valid concerns about inappropriate use, particularly when results are ...

PathogenDx's Microarray Detection Platform is the fastest and most cost-effective test for UTI detection with higher throughput for efficient and accurate diagnosis. Neeraj Jadhav, Industry Analyst at ...

PathogenDx's Microarray Detection Platform is the fastest and most cost-effective test for UTI detection with higher throughput for efficient and accurate diagnosis. SAN ANTONIO, Nov. 11, 2024 ...

Frost & Sullivan recently assessed the multiplexed urinary tract infection detection industry and, based on its findings, recognizes PathogenDx with the 2024 North American New Product Innovation ...